Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
68Ga-FL-031
- Development stage
- Phase 1
- Lead developer
- Union Hospital of Huazhong University of Science and Technology
- Modality
- Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics, Peptides
- Administration
- Intravenous
01
Overview
68Ga-FL-031 is a radiopharmaceutical diagnostic agent developed by Union Hospital, Tongji Medical College, Huazhong University of Science and Technology. It consists of the radionuclide Gallium-68 (68Ga) conjugated to the FL-031 ligand, which specifically targets the Somatostatin receptor type 2 (SSTR2). SSTR2 is frequently overexpressed in various malignancies, including small cell lung cancer, breast cancer, and nasopharyngeal carcinoma. As a Positron Emission Tomography (PET) tracer, 68Ga-FL-031 allows for the non-invasive visualization, diagnosis, and staging of SSTR2-positive tumors. It is currently being evaluated in early-phase clinical trials to compare its diagnostic efficacy against the standard 18F-FDG PET imaging, particularly for identifying metastases and correlating uptake values with immunohistochemical SSTR2 expression.
- Other names
- Gallium-68 FL-031Gallium68 FL-031Gallium 68 FL-03168Ga-labeled FL-031
02
Targets
SSTR2 (Somatostatin receptor type 2)
Beyond the preview
Go deeper on 68Ga-FL-031.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on 68Ga-FL-031.